172 related articles for article (PubMed ID: 38339195)
41. RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial-mesenchymal transition and promotes metastasis of colorectal cancer.
Xiao C; Wu G; Zhou Z; Zhang X; Wang Y; Song G; Ding E; Sun X; Zhong L; Li S; Weng J; Zhu Z; Chen J; Wang X
Cell Death Dis; 2019 Nov; 10(11):833. PubMed ID: 31685801
[TBL] [Abstract][Full Text] [Related]
42. Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer.
Buikhuisen JY; Gomez Barila PM; Cameron K; Suijkerbuijk SJE; Lieftink C; di Franco S; Krotenberg Garcia A; Uceda Castro R; Lenos KJ; Nijman LE; Torang A; Longobardi C; de Jong JH; Dekker D; Stassi G; Vermeulen L; Beijersbergen RL; van Rheenen J; Huveneers S; Medema JP
J Exp Clin Cancer Res; 2023 Mar; 42(1):56. PubMed ID: 36869386
[TBL] [Abstract][Full Text] [Related]
43. Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study.
Haasnoot KJC; Backes Y; Moons LMG; Kranenburg O; Trinh A; Vermeulen L; Noë M; Tuynman JB; van Lent AUG; van Ginneken R; Seldenrijk CA; Raicu MG; Trumpi K; Ubink I; Milne AN; Boonstra JJ; Groen JN; Schwartz MP; Wolfhagen FHJ; Geesing JMJ; Ter Borg F; Brosens LAA; van Bergeijk J; Spanier BWM; de Vos Tot Nederveen Cappel WH; Kessels K; Seerden TCJ; Vleggaar FP; Offerhaus GJA; Siersema PD; Elias SG; Laclé MM;
Mod Pathol; 2020 Dec; 33(12):2626-2636. PubMed ID: 32581367
[TBL] [Abstract][Full Text] [Related]
44. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
45. HERC3 regulates epithelial-mesenchymal transition by directly ubiquitination degradation EIF5A2 and inhibits metastasis of colorectal cancer.
Zhang Z; He G; Lv Y; Liu Y; Niu Z; Feng Q; Hu R; Xu J
Cell Death Dis; 2022 Jan; 13(1):74. PubMed ID: 35064108
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
47. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
48. Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial).
Stahler A; Heinemann V; Schuster V; Heinrich K; Kurreck A; Gießen-Jung C; Fischer von Weikersthal L; Kaiser F; Decker T; Held S; Graeven U; Schwaner I; Denzlinger C; Schenk M; Neumann J; Kirchner T; Jung A; Kumbrink J; Stintzing S; Modest DP
Eur J Cancer; 2021 Nov; 157():71-80. PubMed ID: 34507244
[TBL] [Abstract][Full Text] [Related]
49. A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer.
van den Berg I; Smid M; Coebergh van den Braak RRJ; van de Wiel MA; van Deurzen CHM; de Weerd V; Martens JWM; IJzermans JNM; Wilting SM
Mol Oncol; 2021 Dec; 15(12):3348-3362. PubMed ID: 34510716
[TBL] [Abstract][Full Text] [Related]
50. Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2.
Chang K; Willis JA; Reumers J; Taggart MW; San Lucas FA; Thirumurthi S; Kanth P; Delker DA; Hagedorn CH; Lynch PM; Ellis LM; Hawk ET; Scheet PA; Kopetz S; Arts J; Guinney J; Dienstmann R; Vilar E
Ann Oncol; 2018 Oct; 29(10):2061-2067. PubMed ID: 30412224
[TBL] [Abstract][Full Text] [Related]
51. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.
Li Z; Yang Z; Liu W; Zhu W; Yin L; Han Z; Xian Y; Wen J; Tang H; Lin X; Yang Y; Wang J; Zhang K
J Transl Med; 2023 May; 21(1):302. PubMed ID: 37147666
[TBL] [Abstract][Full Text] [Related]
52. Interconnectivity between molecular subtypes and tumor stage in colorectal cancer.
Coebergh van den Braak RRJ; Ten Hoorn S; Sieuwerts AM; Tuynman JB; Smid M; Wilting SM; Martens JWM; Punt CJA; Foekens JA; Medema JP; IJzermans JNM; Vermeulen L
BMC Cancer; 2020 Sep; 20(1):850. PubMed ID: 32887573
[TBL] [Abstract][Full Text] [Related]
53. Exploratory analyses of consensus molecular subtype-dependent associations of
Smeby J; Sveen A; Bergsland CH; Eilertsen IA; Danielsen SA; Eide PW; Hektoen M; Guren MG; Nesbakken A; Bruun J; Lothe RA
ESMO Open; 2019; 4(3):e000523. PubMed ID: 31321083
[TBL] [Abstract][Full Text] [Related]
54. Appraising the roles of CBLL1 and the ubiquitin/proteasome system for flavivirus entry and replication.
Fernandez-Garcia MD; Meertens L; Bonazzi M; Cossart P; Arenzana-Seisdedos F; Amara A
J Virol; 2011 Mar; 85(6):2980-9. PubMed ID: 21191016
[TBL] [Abstract][Full Text] [Related]
55. Consensus molecular subtype transition during progression of colorectal cancer.
van de Weerd S; Torang A; Zwager LW; Koelink PJ; Koster J; Bastiaansen BA; Lammers V; Longobardi C; Roodhart JM; van Krieken JH; Farina Sarasqueta A; Dekker E; Medema JP
J Pathol; 2023 Nov; 261(3):298-308. PubMed ID: 37681286
[TBL] [Abstract][Full Text] [Related]
56.
Martinou E; Moller-Levet C; Karamanis D; Bagwan I; Angelidi AM
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216396
[TBL] [Abstract][Full Text] [Related]
57. High Expression of LTBP2 Contributes to Poor Prognosis in Colorectal Cancer Patients and Correlates with the Mesenchymal Colorectal Cancer Subtype.
Huang Y; Wang G; Zhao C; Geng R; Zhang S; Wang W; Chen J; Liu H; Wang X
Dis Markers; 2019; 2019():5231269. PubMed ID: 30956730
[TBL] [Abstract][Full Text] [Related]
58. Engineering L7Ae for RNA-Only Delivery Kill Switch Targeting CMS2 Type Colorectal Cancer Cells.
Yang J; Ding S
ACS Synth Biol; 2021 May; 10(5):1095-1105. PubMed ID: 33939419
[TBL] [Abstract][Full Text] [Related]
59. N‑glycosylation and receptor tyrosine kinase signaling affect claudin‑3 levels in colorectal cancer cells.
Pérez AG; Andrade-Da-Costa J; De Souza WF; De Souza Ferreira M; Boroni M; De Oliveira IM; Freire-Neto CA; Fernandes PV; De Lanna CA; Souza-Santos PT; Morgado-Díaz JA; De-Freitas-Junior JCM
Oncol Rep; 2020 Oct; 44(4):1649-1661. PubMed ID: 32945502
[TBL] [Abstract][Full Text] [Related]
60. Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study.
Peters NA; Constantinides A; Ubink I; van Kuik J; Bloemendal HJ; van Dodewaard JM; Brink MA; Schwartz TP; Lolkema MPJK; Lacle MM; Moons LM; Geesing J; van Grevenstein WMU; Roodhart JML; Koopman M; Elias SG; Borel Rinkes IHM; Kranenburg O
Front Oncol; 2022; 12():969855. PubMed ID: 36147916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
